<format type="yaml">{report_id: string, report_date: date, patient_details: {patient_id: string, age_at_reaction: number optional, gender: string, relevant_history: list[string]}, suspected_drugs: list[{drug_name: string, drug_class: string optional, dosage: string, route_of_administration: string, start_date: date, end_date: date optional, indication_for_use: string}], adverse_reactions: list[{symptom_name: string, onset_date: date, severity: string, outcome: string, intervention_required: boolean, intervention_details: string optional}], causality_assessment: {naranjo_score: number optional, assessment_conclusion: string, dechallenge_rechallenge: string}, reporting_facility: string, reporter_type: string, notes: string optional}</format> <data>PHARMACOVIGILANCE CASE REPORT - CONFIDENTIAL
Report Identifier: ADR-2024-950
Date of Submission: 2024-09-25

This report was submitted by a Nurse from Ramirez, Scott and Hall Medical Center concerning patient ANON-PX-3652. The subject is a 26-year-old female with a significant medical history including migraines, asthma, coronary artery disease, hypertension. The facility's standard operating procedure for ADR reporting was followed, and all patient data has been anonymized. The patient chart was reviewed for comorbidities. 

Current medication review revealed the following suspected agent(s): Gabapentin (Anticonvulsant) administered via the Topical route at a dosage of 303mg, initiated on 2024-09-04 for Neuropathic pain and discontinued on 2024-09-24.

On approximately 2024-09-20, the patient began to manifest an adverse event. The primary symptoms noted in the clinical log were Hepatotoxicity, Dizziness. The Hepatotoxicity was classified as Mild in severity. This necessitated clinical intervention. The documented action was: Prescribed say and advised work. The current patient status regarding this symptom is 'Recovered'. The Dizziness was classified as Mild in severity. No specific therapeutic intervention was required. The current patient status regarding this symptom is 'Not Recovered'. 

CAUSALITY ASSESSMENT:
An evaluation of causality was performed. The assessment concluded the relationship was 'Probable'. Dechallenge/Rechallenge status was noted as: 'Positive rechallenge'. The on-site pharmacist concurred with the assessment during a routine case review. 

</data>
report_id: ADR-2024-950
report_date: '2024-09-25'
patient_details:
  patient_id: ANON-PX-3652
  gender: Female
  relevant_history:
  - migraines
  - asthma
  - coronary artery disease
  - hypertension
  age_at_reaction: 26
suspected_drugs:
- drug_name: Gabapentin
  dosage: 303mg
  route_of_administration: Topical
  start_date: '2024-09-04'
  indication_for_use: Neuropathic pain
  drug_class: Anticonvulsant
  end_date: '2024-09-24'
adverse_reactions:
- symptom_name: Hepatotoxicity
  onset_date: '2024-09-20'
  severity: Mild
  outcome: Recovered
  intervention_required: true
  intervention_details: Prescribed say and advised work.
- symptom_name: Dizziness
  onset_date: '2024-09-20'
  severity: Mild
  outcome: Not Recovered
  intervention_required: false
causality_assessment:
  assessment_conclusion: Probable
  dechallenge_rechallenge: Positive rechallenge
reporting_facility: Ramirez, Scott and Hall Medical Center
reporter_type: Nurse
